Ephparma Ltd

Country/Region: China     State/Province: Hong Kong

Main Products: Clenbuterol

Company Introduction
clenbuterol
Company Overview

Business Type: Wholesaler, Trader

Year Established: 2007

Employees: Above 1000 People

Plant Area: 5,000-10,000 square meters

Business Information

Main Markets: South America 12% Africa 8% Eastern Asia 10% Domestic Market 8% North America 10% Eastern Europe 9% Southern Europe 9% Mid East 11% Northern Europe 11% Oceania 12%

Trade Capacity: FOB, EXW, CPT

Contract Manufacturing: OEM Service Offered Design Service Offered

Nearest Port: Hong Kong

Trade & Financial Information

Annual Revenue: Above US$100 Million

Total Revenue: US$5 Million - US$10 Million

Export Revenue: US$1 Million - US$2.5 Million

Annual Output: US$50 Million - US$100 Million

Registered Capital: US$2.5 Million - US$5 Million

Export Percentage: 41% - 50%

Payment Modes: USD, EUR, GBP

Lead Time: 13 days

Import/Export Mode: LLC (Limited Liability Corp)

Product Showcase
clenbuterol

CL-Link > Health & Medicines in China Health & Medicines in Hong Kong Health Care Supplement in China Health Care Supplement in Hong Kong